• GENENTECH INC Financial Overview

  • Income Statement: DNA

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 11.72 B 9.28 B 2.44 B 20.81%
    Gross Profit 10.15 B 8.10 B 2.05 B 20.19%
    Net Income Before Extra Items/Preferred Div 2.77 B 2.11 B 656.00 M 23.69%
    Operating Income 4.24 B 3.21 B 1.03 B 24.37%
  • Cash Flow: DNA

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -101.00 M -432.00 M 331.00 M -327.72%
    Net Cash Flow - Investing 1.86 B 1.68 B 184.00 M 9.87%
    Net Cash Flow/Operating Activities 3.23 B 2.14 B 1.09 B 33.81%
  • Balance Sheet: DNA

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 18.94 B 14.66 B 4.28 B 22.60%
    Total Liabilities 7.04 B 5.18 B 1.85 B 26.35%
    Shareholders Equity 11.90 B 9.48 B 2.43 B 20.39%
  • Key Ratios / Statistics: DNA

    • Valuation

      Price/Earnings (TTM) 25.90
      Price/Sales (TTM) 6.12
      Price/Book (MRQ) 6.03
      Price/Cash Flow (TTM) 26.24
    • Profitability

      Gross Margin 86.60
      Operating Margin 36.16
      Profit Margin 23.62
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.67
      Current Ratio (MRQ) 3.35
      Long Term Debt-to-Equity (MRQ) 18.63
    • Management Effectiveness

      Return on Equity (TTM) 26.22
      Return on Assets (TTM) 17.63
      Return on Investments (TTM) 21.20